384
Views
7
CrossRef citations to date
0
Altmetric
Drug Profile

Racotumomab–alum vaccine for the treatment of non-small-cell lung cancer

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mariano R. Gabri, Walter Cacciavillano, Guillermo L. Chantada & Daniel F. Alonso. (2016) Racotumomab for treating lung cancer and pediatric refractory malignancies. Expert Opinion on Biological Therapy 16:4, pages 573-578.
Read now
Tania Crombet Ramos, Pedro Camilo Rodríguez, Elia Neninger Vinageras, Beatriz Garcia Verdecia & Agustin Lage Davila. (2015) CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer. Expert Review of Vaccines 14:10, pages 1303-1311.
Read now

Articles from other publishers (5)

Lue Sun, Yu Sogo, Xiupeng Wang & Atsuo Ito. (2021) Biosafety of mesoporous silica nanoparticles: a combined experimental and literature study. Journal of Materials Science: Materials in Medicine 32:9.
Crossref
J. Sebastian Temme, Dorothy L. Butler & Jeffrey C. Gildersleeve. (2021) Anti-glycan antibodies: roles in human disease. Biochemical Journal 478:8, pages 1485-1509.
Crossref
Marcela Cortés-Jofré, Rolando Uranga, Ania Torres Pombert, Maria del Carmen Arango Prado, Iraida Caballero Aguirrechu, Cecilia Pacheco, Rosa Maria Ortiz Reyes, Fernando Chuecas & Pedro Inocente Mas Bermejo. (2019) Therapeutic vaccines for advanced non-small cell lung cancer. Cochrane Database of Systematic Reviews.
Crossref
Qinxue Wang, Haobin Huang, Xiaoning Zeng, Yuan Ma, Xin Zhao & Mao Huang. (2016) Single-agent maintenance therapy for advanced non-small cell lung cancer (NSCLC): a systematic review and Bayesian network meta-analysis of 26 randomized controlled trials. PeerJ 4, pages e2550.
Crossref
Walter Cacciavillano, Claudia Sampor, Cecilia Venier, Mariano R. Gabri, María T.G. de Dávila, Maria L. Galluzzo, Marcelo D. Guthmann, Leonardo Fainboim, Daniel F. Alonso & Guillermo L. Chantada. (2015) A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies. Pediatric Blood & Cancer 62:12, pages 2120-2124.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.